C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 16/28 (2006.01) A61K 39/395 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2206471
The invention comprises monovalent mAb fragments (Fab) of mAb which have the ability of downregulate HLA-DR expression on antigen presenting cells. The Fab fragments can downregulate such HLA-DR expression without the cytotoxicity of the parent mAb or of bivalent fragments (F(ab)'2) of the mAb. The Fab fragments of the invention are therefore potent, class II MHC-specific immunosuppressive compounds without cytotoxic side effects.
L'invention porte sur des fragments mAb monovalents (Fab) de mAb qui sont capables de d'atténuer l'expression HLA-DR sur les cellules présentatrices de l'antigène, Les fragments FAB peuvent atténuer cette expression de HLA-DR sans la toxicité des fragments mAb apparentés ou de fragments bivalents (F(ab)'2) du mAb. Les fragments Fab de l'invention sont donc des composés immunosuppresseurs spécifiques du CMH de classe II qui n'ont pas d'effets secondaires cytotoxiques.
Nagy Zoltan
Vidovic Damir
F. Hoffmann-La Roche Ag
Gowling Lafleur Henderson Llp
LandOfFree
Monoclonal antibody fragments having immunosuppressant activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monoclonal antibody fragments having immunosuppressant activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibody fragments having immunosuppressant activity will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1376930